Metropolitan Life Insurance Company (MetLife)’s EyePoint Inc EYPT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,974	Closed	-$40.8K	–	730
2024 Q1	$40.8K	Buy	1,974 +528	+37%	+$13.1K	﹤0.01%	1511
2023 Q4	$33.4K	Hold	1,446	–	–	﹤0.01%	1647
2023 Q3	$11.6K	Hold	1,446	–	–	﹤0.01%	2151
2023 Q2	$12.6K	Buy	+1,446	New	+$8.83K	﹤0.01%	2177
2022 Q4	–	Sell	-1,753	Closed	-$13.9K	–	2356
2022 Q3	$13.9K	Hold	1,753	–	–	﹤0.01%	2189
2022 Q2	$13.8K	Hold	1,753	–	–	﹤0.01%	2223
2022 Q1	$21.3K	Sell	1,753 -4,369	-71%	-$47.9K	﹤0.01%	2060
2021 Q4	$74.9K	Buy	+6,122	New	+$82.4K	﹤0.01%	2613

Other funds holding EYPT

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EYPT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of EyePoint Inc (EYPT) in Q2 2024, closing a stake of 1,974 shares — an estimated $40.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EYPT in Q4 2021 and held it in 8 quarters. The position peaked at $74.9K in Q4 2021. 151 funds tracked by Wall St. Rank hold EYPT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining EyePoint Inc position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,974 EyePoint Inc shares in Q2 2024, an estimated $40.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in EyePoint Inc in Q4 2021 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s EyePoint Inc position peaked at $74.9K in Q4 2021.
151 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.